JNK INDIA IPO SUBSCRIPTION
![Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid?](https://img.etimg.com/thumb/msid-111447023,width-100,height-75,resizemode-4/markets/ipos/fpos/namita-thapar-backed-emcure-pharma-ipo-opens-for-subscription-should-you-bid.jpg)
Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid?
Emcure Pharma IPO: Emcure Pharmaceuticals IPO, with marquee investors like Goldman Sachs, offers a fresh equity issuance and OFS. Namita Thapar to earn Rs 127 crore through the stake sale. The company targets debt repayment and global expansion.
![Bansal Wire IPO booked 5.72 times on Day 2. Check GMP and other details](https://img.etimg.com/thumb/msid-111483730,width-100,height-75,resizemode-4/markets/ipos/fpos/bansal-wire-ipo-booked-nearly-4-times-on-day-2-check-gmp-and-other-details.jpg)
Bansal Wire IPO booked 5.72 times on Day 2. Check GMP and other details
Bansal Wire's IPO has been nearly 4 times oversubscribed on its second day, fueled by robust demand from non-institutional and retail investors. The IPO, conducted through the book-building method, reserves 50% for qualified institutional buyers, 35% for retail investors, and 15% for non-institutional investors.
![Bansal Wire IPO sails through on Day 1 on robust NII, retail demand. Check GMP and other details](https://img.etimg.com/thumb/msid-111455235,width-100,height-75,resizemode-4/markets/ipos/fpos/bansal-wire-ipo-sails-through-on-day-1-on-robust-nii-retail-demand-check-gmp-and-other-details.jpg)
Bansal Wire IPO sails through on Day 1 on robust NII, retail demand. Check GMP and other details
Bansal Wire's IPO saw strong demand from retail and non-institutional investors on the first day, while the QIB portion remained unsubscribed. Proceeds will be used for debt repayment, working capital, and general corporate purposes.
![Bain Capital-backed Emcure Pharma mobilises Rs 583 cr from anchor investors](https://img.etimg.com/thumb/msid-111439332,width-100,height-75,resizemode-4/markets/ipos/fpos/bain-capital-backed-emcure-pharma-mobilises-rs-583-cr-from-anchor-investors.jpg)
Bain Capital-backed Emcure Pharma mobilises Rs 583 cr from anchor investors
Emcure Pharmaceuticals has allocated 57.8 lakh equity shares to 48 funds at the upper end of the IPO price band, raising Rs 582.6 crore. The public subscription for the IPO will commence on July 3rd and conclude on July 5th.
![Bansal Wire IPO to open for subscription on Wednesday. Here's what GMP indicates](https://img.etimg.com/thumb/msid-111432752,width-100,height-75,resizemode-4/markets/stocks/news/bansal-wire-ipo-to-open-for-subscription-on-wednesday-heres-what-gmp-indicates.jpg)
Bansal Wire IPO to open for subscription on Wednesday. Here's what GMP indicates
The company aims to raise approximately Rs 745 crore at the upper end of its price band. Investors can bid for a minimum of 58 shares per lot, with the option to bid in multiples of this lot size. Prior to the IPO subscription, the company's shares were trading at a premium of Rs 65 in the unlisted market.
![Namita Thapar's Emcure Pharmaceuticals IPO opens on Wednesday. What GMP signals ahead of subscription](https://img.etimg.com/thumb/msid-111429411,width-100,height-75,resizemode-4/markets/ipos/fpos/namita-thapars-emcure-pharmaceuticals-ipo-opens-on-wednesday-what-gmp-signals-ahead-of-subscription.jpg)
Namita Thapar's Emcure Pharmaceuticals IPO opens on Wednesday. What GMP signals ahead of subscription
Emcure Pharmaceuticals' IPO opens for subscription on July 3rd with shares trading at a Rs 265 premium in the unlisted market. The IPO includes fresh equity shares worth Rs 800 crore and an Offer For Sale (OFS) of 1.14 crore shares. Priced at Rs 960-1,008 per share, investors can bid for 14 shares per lot. The company targets to raise Rs 1,952 crore at the upper price range.
- Go To Page 1
Sylvan Plyboard stock debuts with 20% premium on NSE SME platform
Sylvan Plyboard's IPO on NSE SME platform debuted with a 20% premium. Reporting revenues of Rs 162 crore and a net profit of Rs 4.47 crore, the company distributes products through authorized dealers and sub dealers.
73% IPOs trading above issue price as primary market shines in H1, four turn multibaggers
The fundraising of Rs 26,272 crore, however fell short of the previous two years likely due to the absence of mega issues. Investors' reception also remained positive with only one failed IPO.
Nephro Care IPO opens today: Check issue size, price band, GMP and other details
Invest in the Nephro Care IPO in Kolkata to support healthcare initiatives and gain potential returns through shares.
Allied Blenders IPO: Check subscription on last day, GMP and other details
The IPO of Allied Blenders and Distillers was subscribed 23.49 times on its third and final day. NIIs show strong interest with 32 times subscription, followed by retail investors at 4.42 times. The QIB portion of the issue was booked 50 times. The IPO combines a Rs 1,000 crore fresh equity sale and OFS of 1.77 crore shares, allowing promoters Bina Kishore Chhabria and Resham Chhabria Jeetendra to reduce their stakes.
Allied Blenders and Distillers IPO subscribed 1.51 times on Day 2. Check subscription, GMP and other details
ABDL's IPO involves a fresh equity sale of Rs 1,000 crore and an offer for sale (OFS) of 1.77 crore shares by promoters Bina Kishore Chhabria and Resham Chhabria Jeetendra. Funds raised will repay borrowings and fund corporate needs. The company's shares are trading with a GMP of Rs 87.
Allied Blenders and Distillers IPO opens for subscription. Should you bid?
Allied Blenders and Distillers IPO, featuring Officer's Choice whiskey, will open for subscription with a price band of Rs 267-281 per share. Promoters will offload part of their stakes, and analysts caution against investing due to high valuation and financial risks.
Allied Blenders IPO to open on Tuesday. What GMP signals ahead of subscription?
Allied Blenders and Distillers, the maker of Officer's Choice Whiskey, is launching a Rs 1,500 crore IPO. The IPO is priced at Rs 267-281 per share, with a premium of Rs 75 in the unlisted market.
Stanley Lifestyles IPO: Issue oversubscribed at 1.43 times on day 1. Check GMP, other details
Stanley Lifestyles' IPO opened for subscription on Friday. It was oversubscribed at 1.43 times. The retail portion was subscribed 1.80 times on Day 1 while the quota available for non-institutional investors was booked 2.01 times.
Stanley Lifestyles IPO opens for subscription. Should you bid?
The net proceeds from the Stanley Lifestyles IPO will be used for expenditure for opening the new stores, anchor stores, and renovating existing stores. The current grey market premium of Stanley Lifestyles is Rs 150 in the unlisted market.
GEM Enviro Management IPO opens today: Check issue size, price band, GMP and other details
The SME IPO of United GEM Enviro Management aims to raise about Rs 45 crore and list shares on BSE SME platform, with a distribution of 50% for QIB investors, 35% for retail investors, and 15% for other investors.
Durlax Top Surface IPO opens today: Check issue size, price band, GMP and other details
Durlax Top Surface SME IPO opened for subscription today aiming to raise Rs 41 crore and list shares on NSE SME platform by June 21.
Dee Development Engineers IPO opens for subscription: Should you bid?
Analysts advised investors to subscribe to Dee Development Engineers IPO as the company emerged as the largest player in process piping solutions in India, in terms of installed capacity. Further, the issue is available at a reasonable valuation considering the future growth potential. SBI Capital Markets and Equirus Capital are the book-running lead managers to the issue.
Ixigo IPO opens for subscription. Should you bid?
Ixigo IPO by Le Travenues Technology will open for subscription with a price band of Rs 88-93 per share. Investors can bid for 161 shares in one lot. The IPO closes on June 12.
Beacon Trusteeship IPO booked 65 times on Day 2; Z-tech India's issue subscribed 8x
Beacon Trusteeship's IPO garners strong investor interest, garnering 66 times bids on the second day of bidding. The company plans to raise funds for technology infrastructure, subsidiary investment, and other corporate purposes.
JNK India shares debut at 50% premium over issue price
JNK India made a strong market debut on NSE and BSE with significant premiums. Specializing in heating equipment for oil & gas sectors, it aims for substantial growth supported by a robust order book.
JNK India shares to debut today. What GMP signals ahead of listing
JNK India has capabilities in thermal designing, engineering, manufacturing, supplying, installing, and commissioning process-fired heaters, reformers, and cracking furnaces.
JNK India IPO allotment: Check status, listing date, GMP and other details
JNK India IPO share allotment details available on BSE/registrar website. Shares trade at Rs 85 premium. IPO price 451, 20% gain. Valuation at P/E 49.38x, EV/EBITDA 33.13x, market cap Rs 2,308 crore. Expertise in thermal designing, 27% market share, FY23 revenue Rs 407 crore."
JNK India IPO subscribed over 28 times on final day. Check subscription, GMP and other details
The IPO comprised fresh equity of up to Rs 300 crore and an offer for sale of up to Rs 84.2 lakh worth shares. Under the OFS, Goutam Rampelli, Dipak Kacharulal, JNK Heaters, Mascot Capital and Marketing, and Milind Doshi will offload shares.
JNK India IPO sails through on Day 2. Check subscription, GMP and other details
JNK India IPO: The offer reserves 50% for qualified institutional buyers, 35% for retail investors, and the remaining 15% for non-institutional investors. The net proceeds will be allocated towards fulfilling working capital needs and other general corporate purposes.
Niche focus, robust orders make JNK India a better long-term bet
The company’s order book has grown six-fold in the past three fiscal years. The company's order bid size has consistently expanded, which has helped in winning large orders.
JNK India IPO sees steady response so far on Day 1. Check subscription, GMP and other details
JNK India received steady response so far on first day. The category reserved for institutional investors was booked the most at 67%, followed by retail investors at 34% and non-institutional investors at 9%.
JNK India IPO opens for subscription. Should you bid?
JNK India IPO GMP, Price Band: JNK India IPO to open for Rs 650 crore with fresh equity and offer for sale. Reserved quotas. Anand Rathi advises subscription. Market cap post issue, price band set. Proceeds for working capital.
JNK India announces price band for its IPO. Check details
The issue closes on April 25 and the anchor investors' allocation will be done on April 22. Investors can bid for a minimum of 36 shares in one lot and in multiples thereafter.
Load More